(Q37533319)

20 August 2017

1 reference

title

Abatacept therapy and safety management (English)

1 reference

20 August 2017

12

Thierry Schaeverbeke

1 reference

20 August 2017

Jacques-Eric Gottenberg

6

object named as

Jacques-Eric Gottenberg

0 references

Éric Hachulla

object named as

Eric Hachulla

8

0 references

Bruno Fautrel

4

object named as

Bruno Fautrel

1 reference

20 August 2017

5

Laure Gossec

1 reference

20 August 2017

13

Daniel Wendling

1 reference

20 August 2017

11

Alain Saraux

1 reference

20 August 2017

14

Xavier Mariette

1 reference

20 August 2017

Thao Pham

1

1 reference

20 August 2017

Pascal Claudepierre

2

1 reference

20 August 2017

Arnaud Constantin

3

1 reference

20 August 2017

Philippe Goupille

7

1 reference

20 August 2017

Charles Masson

9

1 reference

20 August 2017

Jacques Morel

10

1 reference

20 August 2017

Jean Sibilia

15

1 reference

20 August 2017

publication date

1 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

76 Suppl 1

1 reference

20 August 2017

page(s)

S3-S55

1 reference

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Cytokines and T cells in host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Role of T cell costimulation in anti-viral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

The host response of CD28-deficient mice to Pneumocystis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Mortality in established rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Comorbidities in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Update on abatacept: a selective costimulation modulator for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Cardiovascular death in rheumatoid arthritis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Transmission disequilibrium of maternally-inherited CTLA-4 microsatellite alleles in idiopathic recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

The CTLA-4 gene is expressed in placental fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Fetal tolerance in human pregnancy--a crucial balance between acceptance and limitation of trophoblast invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection to the allogeneic fetus in abortion-prone matings

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Association of the A/G polymorphism at position 49 in exon 1 of CTLA-4 with the susceptibility to unexplained recurrent spontaneous abortion in the Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Vaccine responses in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

The mechanism underlying T cell help for induction of an antigen-specific in vivo humoral immune response to intact Streptococcus pneumoniae is dependent on the type of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

The human antibody response to pneumococcal capsular polysaccharides is dependent on the CD40-CD40 ligand interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Antibiotic prophylaxis in dentistry: a review and practice recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2809%2974520-8

7 January 2021

10.1016/S1297-319X(09)74520-8

Identifiers

DOI

1 reference

20 August 2017

1 reference